FDA Issues Clearance: Medical Tech Company Develops Innovative System

FDA Clears Motus GI's Pure-Vu EVS Gastro and Gen 4 Colon: What it Means for You

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

The Food and Drug Administration (FDA) has issued clearance to Motus GI Holdings, Inc. (NASDAQ: MOTS) for their Pure-Vu® EVS Gastro and Gen 4 Colon systems. This groundbreaking development promises a potential…